Shots: On Apr 02, 2020, EMA’s CHMP has recommended Gilead’s Remdesivir to be used for treating COVID-19 in compassionate use programmes in the EU Compassionate use programmes are intended to […]readmore
Tags : Remdesivir
Shots: Gilead has initiated two P-III studies assessing the safety and efficacy of its investigational therapy, Remdesivir in patients with moderate to severe COVID-19 in the UK The two studies […]readmore
Shots: The studies will evaluate 5-day and a 10-day dosing regimen of remdesivir (IV). One study will assess remdesivir + SOC in ~400 patients in a ratio (1:1) with sev. […]readmore